NCT03838237
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +21 more
- Locations
-
- IRCCS Policlinico San Donato San Donato Milanese, Milano, Italy
Clinical trial condition
Sphingolipidoses
Explore clinical trials studying Sphingolipidoses. Study availability and eligibility vary by location and protocol.
390 public trials
81 recruiting studies
Sphingolipidoses trial results
NCT01356537
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
- Locations
-
- Landeskrankenhaus Bregenz Bregenz, Austria
- Paracelsus Medizinische Privatuniversität Salzburg Salzburg, Austria
- AKH, Allgemeines Krankenhaus der Stadt Wien Vienna, Austria
- Medical University of Vienna Vienna, Austria
NCT01355146
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- Landeskrankenhaus Bregenz Bregenz, Austria
- LKH-Universitätsklinikum Graz Graz, Austria
- Paracelsus Medizinische Privatuniversität Salzburg Salzburg, Austria
- Universitätsklinik für Innere Medizin III Vienna, Austria
NCT02939547
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +20 more
- Locations
-
- UCSF Benioff Children's Hospital Oakland Oakland, California, United States
- Atlantic Health System/Morristown Medical Center Morristown, New Jersey, United States
NCT03135197
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- Universtiy Hospital Münster Münster, Germany
Completed
Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease
NCT02194985
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- Clinical Study Site Atlanta, Georgia, United States
- Clinical Study Site Kansas City, Kansas, United States
- Clinical Study Site Grand Rapids, Michigan, United States
- Clinical Study Site New York, United States
NCT04050137
- Conditions
- Behavior, Brain Diseases, Brain Diseases, Metabolic, +22 more
- Locations
-
- FEETEG Zaragoza, Spain
NCT04469894
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +18 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
NCT02228460
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- Investigational Site Number 840002 Atlanta, Georgia, United States
- Investigational Site Number 840003 Cincinnati, Ohio, United States
- Investigational Site Number 840001 Fairfax, Virginia, United States
- Investigational Site Number 250001 Garches, France
Completed
Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease
NCT01427517
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Brain Diseases, Metabolic, +22 more
- Locations
-
- University of Minnesota Minneapolis, Minnesota, United States